Glioblastoma Clinical Trials in Zhuhai, Guangdong
2 recruitingZhuhai, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
Glioblastoma
Guangzhou Virotech Pharmaceutical Co., Ltd.42 enrolled11 locationsNCT07093814
Recruiting
Phase 2
The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
Recurrent Glioblastoma
Fifth Affiliated Hospital, Sun Yat-Sen University20 enrolled1 locationNCT06220552